Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Fentanyl Market From 2025 to 2029?

The market size for fentanyl has seen significant expansion in the past few years. The market will increase from $16.22 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. Factors contributing to this growth in the historic period include the necessity for pain management, medical procedures and surgeries, managing pain in cancer patients, the growth of the opioid analgesic market, and an aging population.

Expectations are high for the fentanyl market to see robust expansion in the coming years, with projected growth to “$22.03 billion by 2029, showcasing a compound annual growth rate (CAGR) of 6.5%. This forecasted growth can be ascribed to factors such as rising instances of chronic pain, wider application of oncology treatments, increase in surgical procedures, public health campaigns, as well as regulatory greenlights for new medical uses. Key predicted trends for the forecast period involve breakthroughs in drug formulation technology, innovative strides in detecting usage, public health and harm reduction tactics, surge in pharmaceutical applications, and global cooperation and data exchange.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13237&type=smp

What Elements Are Contributing To Growth In The Fentanyl Market?

The escalating occurrence of chronic ailments is anticipated to fuel the expansion of the fentanyl market in the future. Chronic illness refers to a health issue that lingers for an extended length of time, usually at least three months and frequently lasts throughout an individual’s lifetime. Fentanyl is primarily utilized in chronic illnesses to control severe, constant pain that other drugs or treatments fail to effectively manage. For example, according to the Heart Disease Facts issued by the US-based public health agency, the Centers for Disease Control and Prevention (CDC), in the United States in October 2024, coronary heart disease (CHD) caused 371,506 deaths in 2022, adding up to the total 702,880 heart disease deaths, which represented approximately one in every five deaths. Hence, the growing prevalence of chronic diseases is propelling the fentanyl market’s expansion.

The fentanyl market covered in this report is segmented –

1) By Type: Fentanyl Injections, Fentanyl TTS (Transdermal Therapeutic System)

2) By Application: Inducting Anesthesia, Maintain Anesthesia, General Analgesic, Postoperative Analgesia, Breakthrough Cancer Pain

3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Fentanyl Injections: Injectable Solutions, Premixed Injection Formulations

2) By Fentanyl TTS (Transdermal Therapeutic System): Patch Formulations, Matrix Patch Systems

What Trends Are Currently Influencing Growth In The Fentanyl Market?

Fentanyl market leaders like Indivior PLC have been working on innovative products like Opvee to increase their customer base, boost sales, and enhance revenues. Opvee (nalmefene) serves as a robust opioid receptor blocker intended to treat established or presumptive opioid overdoses caused by natural or synthetic opioids such as fentanyl. In May 2023, the U.S. Food and Drug Administration granted approval for Indivior PLC’s Opvee nasal spray. The spray works by counteracting the impact of opioids on the brain, aiding recently overdosed patients in regaining normal blood pressure and respiration. The ability to easily administer Opvee in nasal spray form during emergencies makes it an invaluable part of the arsenal of drugs used to fight opioid overdoses and save lives.

Who Are The Key Contributors To Growth In The Fentanyl Market?

Major companies operating in the fentanyl market report are Pfizer Inc., Johnson & Johnson, Sinopharm Group, Merck & Co. Inc., Bayer AG, Novartis AG, Kyowa Kirin Co. Ltd., Fresenius Kabi Oncology Ltd., Abbott Laboratories, Sanofi S.A, Boehringer Ingelheim GmbH, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, AstraZeneca PLC, Apotex Inc., Hisamitsu Pharmaceutical Co. Inc., Alvogen, Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Insys Therapeutics Inc., Exela Pharma Sciences LLC, Paladin Labs Inc., Bryant Ranch Prepack Inc., Galena Biopharma Inc., Validus Pharmaceuticals LLC, Quality Care Products LLC, Dispensing Solutions Inc.

https://www.thebusinessresearchcompany.com/report/fentanyl-global-market-report

Which Region Is Projected To Lead The Fentanyl Market By 2025?

North America was the largest region in the fentanyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13237&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model